Immunological mechanisms of vaccine-induced protection against COVID-19 in humans

Sadarangani, Manish, Marchant, Arnaud, Kollmann, Tobias R.·2021·Nature Reviews Immunology
DOI 10.1038/s41577-021-00578-z

Cited by (513)

Items 301–400 of 513

  1. Effect of Heterologous Vaccination Regimen with Ad5-nCoV CanSinoBio and BNT162b2 Pfizer in SARS-CoV-2 IgG Antibodies Titers
    María Elena Romero-Ibarguengoitia, Arnulfo González‐Cantú, Yodira Guadalupe Hernández-Ruíz, Ana Gabriela Armendariz-Vázquez, Diego Rivera-Salinas, Laura Patricia Montelongo-Cruz, Gerardo Francisco Del Rio-Parra, Irene Antonieta Barco-Flores, Rosalinda González-Facio, Miguel Ángel Sanz‐Sánchez · 2022 · Vaccines
  2. High Frequencies of PD-1 + TIM3 + TIGIT + CTLA4 + Functionally Exhausted SARS-CoV-2-Specific CD4 + and CD8 + T Cells Associated with Severe Disease in Critically ill COVID-19 Patients
    Pierre-Gregoire A. Coulon, Swayam Prakash, Nisha Rajeswari Dhanushkodi, Ruchi Srivastava, Latifa Zayou, Delia F. Tifrea, Robert A. Edwards, J. Figueroa Cesar, Sebastian Dominik Schubl, Lanny L. Hsieh et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  3. A retrospective evaluation of seroconversion after COVID-19 during the early Omicron wave in fully vaccinated multiple sclerosis patients receiving anti-CD20 therapies
    Sharon S. Stoll, Shree Desai, Elle Levit · 2023 · Multiple Sclerosis and Related Disorders
  4. COVID-19 vaccination effectiveness: a review in early vaccine adopters in Asian Countries.
    2022
  5. Re-Emerging COVID-19: Controversy of Its Zoonotic Origin, Risks of Severity of Reinfection and Management
    Bayissa Chala, Tigist Tilaye, Gemechis Waktole · 2023 · International Journal of General Medicine
  6. COVID-19 vaccines effectiveness against symptomatic disease and severe outcomes, 2021–2022: a test-negative case–control study
    Cátia S. Brazete, Jessica Brazete, Fabio Alves, Ana Aguiar, A.M. Gonçalves, M. Cardoso, L. Sá, Eugénio Moita Gonçalves, Marta Sofia de Sousa Pinto, Raquel Duarte · 2023 · Public Health
  7. Serological Evaluation of Antibody Titers After Vaccination Against COVID-19 in 18-44-Year-Old Individuals at a Tertiary Care Center
    Rachita Nanda, Prishni Gupta, Anjan Kumar Giri, Suprava Patel, Seema Shah, Eli Mohapatra · 2023 · Cureus
  8. Systemic profiling of immune responses in healthy adults vaccinated with an RBD-targeting COVID-19 mRNA vaccine
    Zhou, Chao, Sun, Mengxu, Huang, Xingyao, Liu, Pu, Ouyang, Zhangyi, Wu, Mei, Yuan, Lin, Chen, Jingjing, Shu, Wenjie, Cao, Tianshu et al. · 2025 · hLife
  9. Designing an Epitope-Based Peptide Vaccine Derived from RNA-Dependent RNA Polymerase (RdRp) against Dengue Virus Serotype 2
    Irma Febrianti Wahongan, Elly Juliana Suoth, Fatimawali Fatimawali, Saad Alhumaid, Hawra Albayat, Mohammed Mubarak Aljeldah, Basim R. Al Shammari, Mutaib M. Mashraqi, Ahmad A. Alshehri, Tarek Sulaiman et al. · 2022 · Vaccines
  10. Humoral and cellular immunity to SARS-CoV-2 Ancestral and Omicron BA.5 variants following vaccination in myelofibrosis patients
    Ahmad Alcheikh, Griffith Boord Perkins, Phillippa A. Pucar, Amelia Cecchin, Cheng Sheng Chai, Matthew J. Tunbridge, Anouschka Akerman, Anupriya Aggarwal, Vanessa Milogiannakis, Stuart Grant Turville et al. · 2023 · Blood Cancer Journal
  11. Global COVID-19 vaccination in infants and children: Effectiveness, safety, and challenges
    Watsamon Jantarabenjakul, Napaporn Chantasrisawad, Rapisa Nantanee, Sateesh Ganguli, Thanyawee Puthanakit · 2023 · Asian Pacific Journal of Allergy and Immunology
  12. Comparison of Post-Vaccination Response between mRNA and Vector Vaccines against SARS-CoV-2 in Terms of Humoral Response after Six Months of Observation
    Sebastian Słomka, Patrycja Zięba, Oskar Rosiak, Anna Piekarska · 2023 · Vaccines
  13. Coronavirus Disease 2019 Messenger RNA Vaccines Associated With Delayed Onset of Breakthrough Infections and Fewer Radiographic Abnormalities
    Xin Li, Jacky Man Chun Chan, Bosco Hoi Shiu Lam et al. · 2022 · Clinical Infectious Diseases
  14. Evaluation of long-term antibody kinetics in healthcare workers vaccinated with inactivated COVID-19 Vero cell vaccine (CoronaVac), a propensity score-matched observational study
    2022
  15. Interaction between spike protein of SARS-CoV-2 and human virus receptor ACE2 using two-color fluorescence cross-correlation spectroscopy
    2021
  16. Safety and efficacy of mRNA vaccines: a mechanistic and public health perspective
    Anna K. Blakney, Karina A. Top, Benjamin John Cowling, Heidi Jane Larson, Robin J. Shattock, Manish Sadarangani · 2026 · The Lancet
  17. Prior SARS‐CoV‐2 infection balances immune responses triggered by four EMA‐approved COVID‐19 vaccines: An observational study
    Roberto Lozano‐Rodríguez, Verónica Terrón‐Arcos, Karla Marina Montalbán-Hernández, José Carlos Casalvilla‐Dueñas, Marta Bergón-Gutiérrez, Alejandro Pascual‐Iglesias, Jaime Valentín Quiroga, Luis Augusto Aguirre, Rebeca Pérez de Diego, Carmen Vela et al. · 2022 · Clinical and Translational Medicine
  18. Comparison of Anti-SARS-CoV-2 IgG Antibody Responses Generated by the Administration of Ad26.COV2.S, AZD1222, BNT162b2, or CoronaVac: Longitudinal Prospective Cohort Study in the Colombian Population, 2021/2022
    2022
  19. RNA-based drugs: current, imminent and possible therapeutic applications
    Sebastiano Alfio Torrisi, Federica Geraci, Lidia Diolosà, Angelina De Luca, Luca Falzone, Filippo Drago, Massimo Libra, Gian Marco Leggio · 2025 · Pharmacology & Therapeutics
  20. Herpetic endotheliitis and stromal keratitis following inactivated COVID ‐19 vaccination
    Mehrdad Mohammadpour, Hossein Farrokhpour, Reza Sadeghi · 2022 · Clinical Case Reports
  21. Vaccination status for mild and asymptomatic infections with SARS‐CoV‐2 Omicron BA.2 variant in Shanghai
    Yong Yin, Jilei Lin, Shuhua Yuan, Shilu Tong, Yi He, Bin Dong, Fen Zhang, Erzhen Chen, Junhua Zheng, Wei J. Wang · 2023 · Journal of Medical Virology
  22. mRNA or ChAd0x1 COVID-19 Vaccination of Adolescents Induces Robust Antibody and Cellular Responses With Continued Recognition of Omicron Following mRNA-1273
    Alexander C. Dowell, Annabel A. Powell, Christopher Davis, Sam Scott, Nicola A. Logan, Brian J. Willett, Rachel K. Bruton, Morenike Ayodele, Elizabeth Jinks, Juliet Gunn et al. · 2022 · Frontiers in Immunology
  23. Impact of inactivated vaccines on decrease of viral RNA levels in individuals with the SARS-CoV-2 Omicron (BA.2) variant: A retrospective cohort study in Shanghai, China
    Peng Yang, Bianli Dang, Wen Kang, Xiaofeng Li, Tianping Wang, Ruijuan Li, Meijuan Peng, Yushen Liu, Linxu Wang, Yan H. Cheng et al. · 2023 · Frontiers in Public Health
  24. High Levels of Anti-SARS-CoV-2 Receptor-Binding Domain (RBD) Antibodies One Year Post Booster Vaccinations among Hospital Workers in Indonesia: Was the Second Booster Needed?
    Amila Hanifan Muslimah, Marita Restie Tiara, Hofiya Djauhari, Muhammad H afizh Dewantara, Evan Susandi, Agnes Rengga Indrati, Bachti Alisjahbana, Arto Yuwono Soeroto, Rudi Wisaksana · 2023 · Vaccines
  25. Perspective Overview of Changing Population Immunity to COVID-19 in the Context of Infection, Vaccination, and Emerging SARS-CoV-2 Variants
    Ranjan Ramasamy · 2025 · Pathogens
  26. Cardiac arrhythmias: the growing role of autoantibodies in diagnosis and treatment
    Funsho E. Fakuade, Jana Grune, Niels Voigt · 2024 · European Heart Journal
  27. Immunogenicity and reactogenicity of heterologous prime-boost vaccination with inactivated COVID-19 and ChAdOx1 nCoV-19 (AZD1222) vaccines, a quasi-experimental study
    Kriangkrai Tawinprai, Pawornrath Jungsomsri, Onnicha Pinijnai, Fahsiri Tavonvunchai, Anchisa Lievjaroen, Paphada Suwannaroj, Taweegrit Siripongboonsitti, Thachanun Porntharukchareon, Gaidganok Sornsamdang, Teerapat Ungtrakul · 2023 · Human Vaccines & Immunotherapeutics
  28. Receiving COVID-19 vaccine, hospitalization, and outcomes of patients with COVID-19: A prospective study
    Deldar Morad Abdulah, Abbas Muhammed Sadiq Mirza · 2022 · Monaldi Archives for Chest Disease
  29. Comparative Assessment of the Kinetics of Cellular and Humoral Immune Responses to COVID-19 Vaccination in Cancer Patients
    Lina Souan, Hikmat Abdel‐Razeq, Muna Al Zughbieh, Sara Al Badr, Maher A. Sughayer · 2023 · Viruses
  30. Evaluation of serum soluble HLA-G levels post-recovery from COVID-19 and post-vaccination (Sinopharm and Pfizer-BioNTech)
    2022
  31. The anti-SARS-CoV-2 immunoglobulin G levels and neutralising capacities against alpha and delta virus variants of concern achieved after initial immunisation with vector vaccine followed by mRNA vaccine boost are comparable to those after double immunisation with mRNA vaccines
    Ruben Rose, Franziska Neumann, Olaf Grobe, Thomas Lorentz, Helmut Fickenscher, Andi Krumbholz · 2021 · medRxiv
  32. B-Cell Responses to Sars-Cov-2 mRNA Vaccines
    Lela Kardava, Clarisa M. Buckner, Susan L. Moir · 2022 · Pathogens and Immunity
  33. Impact of Vaccination and Prior Infection on SARS-CoV-2 Viral Load in Preschool Children During the Omicron Pandemic
    2025
  34. Humoral and cellular response after BNT162b2 vaccine booster in hemodialysis patients and kidney transplant recipients
    2023
  35. Effectiveness of Comirnaty® Vaccine and Correlates of Immunogenicity and Adverse Reactions: A Single-Center Prospective Case Series Study
    Diego Fernández‐Lázaro, Manuel Garrosa, Nerea Sánchez-Serrano · 2022 · Vaccines
  36. SARS‐CoV‐2 targeting by RNAi and host complement inhibition: A two‐pronged subterfuge for COVID‐19 treatment
    2021
  37. Disturbances of menstrual cycle after immunization against SARS‐CoV‐2 and their risk factors: Cross‐sectional clinical study
    2023
  38. Humoral and cellular immune responses and their kinetics vary in dependence of diagnosis and treatment in immunocompromised patients upon COVID-19 mRNA vaccination
    2021
  39. Proteomic and serologic assessments of responses to mRNA-1273 and BNT162b2 vaccines in human recipient sera
    Thomas E. Hickey, Uma S. Mudunuri, Heidi Hempel, Troy J. Kemp, Nancy Roche, Keyur Talsania, Brian A. Sellers, James M. Cherry, Lígia A. Pinto · 2025 · Frontiers in Immunology
  40. Immunogenicity and risk factors for poor humoral immune response to SARS-CoV-2 vaccine in patients with autoimmune hepatitis: a systematic review and meta-analysis
    Zhaoxu Tian, Yonghua Chen, Yingxin Yao, Lihua Chen, Xiakai Zhu, Zhaocong Shen, Shanwei Yang, Hang-bin Jin · 2024 · Revista Española de Enfermedades Digestivas
  41. Efficacious nanomedicine track toward combating COVID-19
    Sameh A. Mohammed, Esraa Ibrahim A. Shaaban · 2022 · Nanotechnology Reviews
  42. Humoral immunity of BBIBP‐CorV (Sinopharm) in kidney transplant recipients: Is it time to revise vaccination strategies
    2022
  43. RapidQ: A reader-free microfluidic platform for the quantitation of antibodies against the SARS-CoV-2 spike protein
    Juha‐Pekka Mattila, Arlene Amaro, Monica Longo, James F. Antaki, Sanam Koirala, Alberto Gandini · 2022 · Biomicrofluidics
  44. A systematic review and meta-analysis of the seroconversion rates and adverse effects of COVID-19 mRNA vaccine and COVID-19 viral vector vaccine in kidney transplant recipient patients
    Sikai Chen, Wenxin Wei, Fengyu Huang, Jing Wang, Xingyu Li, Zhixin Geng, Feng Gao, Taiwei Dong, Pei-Feng Wei, Xinbo Yang et al. · 2023 · Human Vaccines & Immunotherapeutics
  45. Anti-SARS-Cov-2 S-RBD IgG Formed after BNT162b2 Vaccination Can Bind C1q and Activate Complement
    Anas H. A. Abu-Humaidan, Fatima M. Ahmad, Dima Awajan, Raba’a F. Jarrar, Nader Alaridah · 2022 · Journal of Immunology Research
  46. SARS-CoV-2 infection in fully vaccinated individuals of old age strongly boosters the humoral immune response
    2021
  47. Immune response after vaccination using inactivated vaccine for coronavirus disease 2019
    2023
  48. The characteristics of TCR CDR3 repertoire in COVID-19 patients and SARS-CoV-2 vaccine recipients
    Dewei Zhou, Yan Qing Luo, Qingqing Ma, Yuanyuan Xu, Xinsheng Yao · 2024 · Virulence
  49. Immune Responses to COVID-19 Vaccines in Patients with Chronic Kidney Disease and Lead Exposure
    Ju‐Shao Yen, Yao‐Cheng Wu, Ju-Ching Yen · 2022 · International Journal of Molecular Sciences
  50. CLEC5A Activation in Inflammatory Monocytes: A Mechanism for Enhanced Adaptive Immunity Following COVID-19 mRNA Vaccination in a Preclinical Study
    2025
  51. Posner-Schlossman syndrome relapse following inactivated COVID-19 vaccination in China
    2023
  52. Immune response to BNT162b2 SARS-CoV-2 vaccine in patients living with HIV: The COVIH-DAPT study
    Sabrina Manni, Caroline Ruetsch-Chelli, Roxane Fabre, Michel Ticchioni, Daisy Graça, Christian Pradier, Barbara Seitz‐Polski, Laurène Lotte, Vesna Brglez, Matteo Vassallo · 2023 · Frontiers in Immunology
  53. Evaluación de la respuesta de los anticuerpos IGG específicos contra SARS-CoV-2 en el personal de salud con el esquema completo de la vacuna Sputnik V (Gam-COVID-Vac)
    Ezequiel Córdova, María Inés Lespada, Diego M. Cecchini, Fabiola Nieto, Susana Palonsky, Mariana Badran, Silvina Virginia Bernasconi, Brenda Bacelar, Laura Morganti, F. Garibaldi et al. · 2022 · Vacunas
  54. Case report: subacute thyroiditis after receiving SARS-CoV-2 vaccine, maybe not only adjuvants
    Yizhou Huang, Xingyu Chen, Qing Wang, Xiaowei Lei, Lili Zhang · 2022 · Frontiers in Medicine
  55. Antibody Response to SARS-CoV-2 in Relation to the Contributing Factors in COVID-19 Patients
    Hafsa Aziz, Shazia Fatima, Humera Mahmood, Shahkhalid Muhammad, Muhammad Abdul Rehman Saeed, Shaista Khurshid, Wardah Aslam, Saeeda Aziz, Mohammad Faheem · 2022 · Viral Immunology
  56. SARS-CoV-2 and Influenza Vaccines in People with Excessive Body Mass—A Narrative Review
    Julia Drożdżyńska, Wiktoria Jakubowska, Marika Kemuś, Martyna Krokowska, Konrad Karpezo, Marcelina Wiśniewska, Paweł Bogdański, Damian Skrypnik · 2022 · Life
  57. The Assessment of Anti–SARS‐CoV‐2 Antibodies in Different Vaccine Platforms: A Systematic Review and Meta‐Analysis of COVID‐19 Vaccine Clinical Trial Studies
    Mohammad Mirzakhani, Maryam Bayat, Mohammadreza Dashti, Safa Tahmasebi, Maryam Rostamtabar, Hadi Esmaeili Gouvarchin Ghaleh, Jafar Amani · 2024 · Reviews in Medical Virology
  58. Differential expression of Type I interferon and inflammatory genes in SARS‐CoV‐2‐infected patients treated with monoclonal antibodies
    2023
  59. Impact of bariatric surgery on the effectiveness of serological response after COVID-19 vaccination
    2022
  60. Preclinical safety evaluation of intradermal SARS-CoV-2 inactivated vaccine (Vero cells) administration in macaques
    2023
  61. Traditional herbal compounds as candidates to inhibit the SARS-CoV-2 main protease: an in silico study
    2022
  62. Deciphering deaths associated with severe serious adverse events following SARS-CoV-2 vaccination: A retrospective cohort study
    2024
  63. Peripheral Nervous System Complications after COVID-19 Vaccination.
    2025
  64. Predominant T-cell epitopes of SARS-CoV-2 restricted by multiple prevalent HLA-B and HLA-C allotypes in Northeast Asia
    2025
  65. Alleviated symptoms of SARS‐CoV‐2 Omicron variant infection in chronic hepatitis B patients with immune control
    2023
  66. Anti-NMDAR Encephalitis and Myasthenia Gravis Post-COVID-19 Vaccination: Cases of Possible COVID-19 Vaccination-Associated Autoimmunity
    Astra Dea Simanungkalit, Vivien Puspitasari, Jacqueline Tasha Margono, Pamela Tiffani, Reza Stevano · 2022 · Open Access Macedonian Journal of Medical Sciences
  67. The Role of Hyperarousal and Aberrant Salience in the Acceptance of Anti-COVID-19 Vaccination
    Fiammetta Iannuzzo, Rosa De Stefano, Maria Catena Silvestri · 2023 · Medicina
  68. Impact of COVID-19 Vaccination on Hospitalization and Mortality: A Comparative Analysis of Clinical Outcomes During the Early Phase of the Pandemic
    Brenda Garduño-Orbe, Paola Selene Palma-Ramírez, Eduardo López‐Ortiz, Gabriela García-Morales, Juan Manuel Sánchez-Rebolledo, Alexis Emigdio-Loeza, Anel Gómez‐García, Geovani López-Ortiz · 2025 · Infectious Disease Reports
  69. Essential role of CD56dimNKG2C+ NK cells trained by SARS-CoV-2 vaccines in protecting against COVID-19
    Huiwen Zheng, Yanli Chen, Jing Li, Yifan Zhang, Heng Li, Xin Zhao, Zhanlong He, Yun Liao, Zihan Zhang, Haijing Shi et al. · 2025 · Molecular Therapy
  70. Timing of musculoskeletal steroid injections in pain practice during Coronavirus disease 2019 (COVID-19) vaccine administration
    Kyung-Hoon Kim · 2021 · The Korean journal of pain
  71. Rapid detection of systemic and mucosal antibody responses to COVID-19 infection or vaccination.
    2025
  72. Neutralization Activity against SARS-CoV-2 Variants after Booster Vaccination in Populations without COVID-19: A Meta-Analysis
    Haoyue Cheng, Zhicheng Peng, Shuting Si, Xialidan Alifu, Haibo Zhou, Peihan Chi, Yan Zhuang, Minjia Mo, Yunxian Yu · 2022 · Vaccines
  73. The protection quest is a primary key to sharing the neutralizing antibody response to cover against all emerging VOCs based on BIV1-CovIran studies
    Maryam Shafaati, Kowsar Bagherzadeh, Majid Lotfinia et al. · 2023 · Heliyon
  74. Assessment of the humoral immunity induced by Sputnik V Covid-19 vaccine (GAM-COVID-VAC) in healthcare workers
    Ezequiel Córdova, María Inés Lespada, Diego M. Cecchini, Fabiola Nieto, Susana Palonsky, Mariana Badran, Silvina Virginia Bernasconi, Brenda Bacelar, Laura Morganti, F. Garibaldi et al. · 2022 · Vacunas (English Edition)
  75. Miller-Fisher Syndrome following the first dose of Comirnaty (Pfizer COVID-19 vaccination)
    2021
  76. Cellular and Molecular Mechanisms of Pathogenic and Protective Immune Responses to SARS-CoV-2 and Implications of COVID-19 Vaccines
    Sheikh Mohammad Fazle Akbar, Mamun Al Mahtab, Sakirul Khan · 2023 · Vaccines
  77. SARS-CoV-2 Immunity: Review of Immune Response to Infection and Vaccination
    Rahnuma Ahmad · 2021 · Bangladesh Journal of Medical Science
  78. Innovation-driven trend shaping COVID-19 vaccine development in China
    Yuntao Zhang, Yuxiu Zhao, Hongyang Liang, Ying Ming Xu, Chuge Zhou, Yuzhu Yao, Hui Wang, Xiaoming Yang · 2023 · Frontiers of Medicine
  79. A Retrospective Population Study of 385 191 Positive Real-Time Reverse Transcription–Polymerase Chain Reaction Tests For SARS-CoV-2 from a Single Laboratory in Katowice, Poland from April 2020 to July 2022
    Emilia Morawiec, Anna Bednarska‐Czerwińska, Adam Pudełko, Anna Strychalska, Mateusz Broncel, Dorota Sagan, Andrzej Madej, Agata Jasińska-Balwierz, Rafał Staszkiewicz, Dawid Sobański et al. · 2022 · Medical Science Monitor
  80. Antibody titers of individuals vaccinated for COVID-19: A systematic review
    Aminoddin M Domado, Homobono Adaza, Andrea P. Beltrán, Leila M Buenviaje, Catherine D Co, Leira R Combalicer, Shiela May A Corona, John Cruz, Maria Adrianne Camille G Dinjotian, Eli Marie S Esperanzate et al. · 2023 · Journal of Biosciences
  81. Overview of immunological & virological factors driving the evolution & global spread of SARS-CoV-2 variants
    Ranjan Ramasamy · 2023 · International Journal of Microbiology Research
  82. Innate immune response in COVID-19: single-cell multi-omics profile of NK lymphocytes in a clinical case series
    Silvia Barbon, Fabrizio Armellin, Verena Passerini, Sergio De Angeli, Simona Primerano, Laura Del Pup, Elisabetta Durante, Veronica Macchi, Raffaele De, Pier Paolo Parnigotto et al. · 2024 · Cell Communication and Signaling
  83. Analysis of humoral and cellular immunity after SARS-CoV-2 vaccination in patients with multiple sclerosis treated with immunomodulatory drugs
    Virginia Meca‐Lallana, Laura Esparcia-Pinedo, Clara Aguirre, Carolina Díaz-Pérez, Ainhoa Gutiérrez-Cobos, Mónica Sobrado, Estefanía Carabajal, Beatriz del Río, Noelia Ropero, José Ramón Villagrasa et al. · 2023 · Clinical Immunology Communications
  84. Effect of COVID-19 inactivated vaccine on peripheral blood anti-β2-GPI antibody and outcomes in vitro fertilization-embryo transplantation
    Huiling Zhou, Yilu Zou, Yujia Guo, Xiaoting Lv, Jiajing Chen, Xinxin Guo, Qicai Liu · 2023 · International Immunopharmacology
  85. Emergence of SARS‐CoV‐2 spike protein at the vaccination site
    2023
  86. Bidirectionality between Cardiometabolic Diseases and COVID-19: Role of Humoral Immunity
    Elaine A. Yu, Rachael P. Jackman, M. Glesby, K. Narayan · 2023 · Advances in Nutrition
  87. P robiotics i nfluencing r esponse of a ntibodies over t ime in s eniors after CO VID-19 v accine (PIRATES-COV): a randomised controlled trial protocol
    Jean‐Charles Pasquier, Mélanie Plourde, Sheela Ramanathan, Nils Chaillet, Guy Boivin, Isabelle Laforest‐Lapointe, Hugues Allard‐Chamard, Geneviève Baron, Jean‐François Beaulieu, Tamàs Fülöp et al. · 2025 · BMJ Open
  88. The association of three vaccination doses with reduced gastrointestinal symptoms after severe acute respiratory syndrome coronavirus 2 infections in patients with inflammatory bowel disease
    Yu Hong, Tianyi Che, Xiangguo Shen, Jie Chen, Kui Wang, Lingying Zhao, Weitong Gao, Yao Zhang, Wensong Ge, Yubei Gu et al. · 2024 · Frontiers in Medicine
  89. Opportunities and challenges for the adoption of novel platform technologies to develop veterinary bacterial vaccines.
    2025
  90. Spatiotemporal Dynamic Immunomodulation by Infection‐Mimicking Gels Enhances Broad and Durable Protective Immunity Against Heterologous Viruses
    Seung Mo Jin, Ju Hee Cho, Yebin Seong, W. A. Gayan Chathuranga, Yejin Gwak, Young‐Woock Noh, Min‐Ho Lee, Sang‐Seok Oh, Jin‐Ho Choi, Jong‐Soo Lee et al. · 2025 · Advanced Science
  91. BCEDB: a linear B-cell epitopes database for SARS-CoV-2
    2023
  92. Vaccination versus natural infection: A review of antibody differentiation techniques
    Vaishnavi Himanshu Mishra, Pratham Gupta, Nandkishor Jageshwar Bankar, Obaid Noman · 2025 · Journal of Research in Medical Sciences
  93. Immune responses and transcription landscape of adults with the third dose of homologous and heterologous booster vaccines of COVID-19
    Hui Zheng, Cuidan Li, Xiuyu Zheng, Hu-Dachuan Jiang, Yuqing Li, Aihua Yao, Xiaolong Li, Feiyu Wang, Wenqing Liu, Xiang Cao et al. · 2024 · Frontiers in Immunology
  94. Microfluidic-assisted single-cell RNA sequencing facilitates the development of neutralizing monoclonal antibodies against SARS-CoV-2
    Ziwei Wang, Amelia Siqi Huang, Lingfang Tang, Jianbin Wang, Guanbo Wang · 2024 · Lab on a Chip
  95. pH‐Responsive Biomineralized Probiotic for Self‐Amplifying Mucosal Vaccination: Gut‐Engineered Antigen Factories Drive Targeted Cervical Tumor Regression
    2026
  96. Aspects and issues of marketing authorisation and use of medicinal products for COVID-19 prevention during the pandemic
    Солдатов Александр Алексеевич, Горенков Дмитрий Витальевич, Вадим Анатольевич Меркулов, В. П. Бондарев · 2022 · Biological Products Prevention Diagnosis Treatment
  97. Design and Clinical Translation of Next-Generation mRNA Vaccines Against Rapidly Mutating Viral Strains
    Shayanki Lahiri, Glenn A. McConkey · 2023 · Infectra
  98. Optimized multi-epitope neoantigen human cytomegalovirus vaccine based on adenovirus vectors elicits potent antiviral immunity
    Shasha Jiang, Xianjuan Zhang, Heping Zhao, Fengjun Liu, Zonghui Li, Xiaoli Yang, Wenxuan Liu, Jing Lv, Yi Zhang, Yiran Zhang et al. · 2025 · Frontiers in Immunology
  99. Evaluation of the efficacy, safety and influencing factors of concomitant and sequential administration of viral respiratory infectious disease vaccines: a systematic review and meta-analysis
    Dafeng Lu, Yifang Han, Ruowei Xu, Mingke Qin, Jianwei Shi, Caihong Zhang, Jinhai Zhang, Fuqiang Ye, Zhenghan Luo, Yuhe Wang et al. · 2023 · Frontiers in Immunology
  100. Association between history of HBV vaccine response and anti-SARS-CoV-2 spike antibody response to the BioNTech/Pfizer’s BNT162b2 mRNA SARS-CoV-2 vaccine among healthcare workers in Japan: A prospective observational study
    Momoko Iwamoto, Akira Ukimura, Taku Ogawa, Fumiko Kawanishi, Naofumi Osaka, Mari Kubota, Tatsuhiko Mori, Ritsuko Sawamura, Masami Nishihara, Tomio Suzuki et al. · 2022 · PLoS ONE